{"id":1175983,"date":"2021-12-23T08:28:51","date_gmt":"2021-12-23T07:28:51","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1175983"},"modified":"2021-12-23T08:28:51","modified_gmt":"2021-12-23T07:28:51","slug":"aifa-approva-il-vaccino-nuvaxovid-novavax","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/aifa-approva-il-vaccino-nuvaxovid-novavax\/","title":{"rendered":"AIFA approva il vaccino Nuvaxovid (Novavax)"},"content":{"rendered":"<p>photo by Natalyia Vaitkevic<\/p>\n<p>&nbsp;<\/p>\n<p>La Commissione Tecnico Scientifica (CTS) di AIFA, nella riunione del 22 dicembre 2021, ha approvato l\u2019utilizzo del vaccino Nuvaxovid (Novavax), rendendolo disponibile nell\u2019intera indicazione autorizzata da EMA per i soggetti di et\u00e0 uguale o superiore ai 18 anni. La vaccinazione prevede un ciclo vaccinale primario di due dosi a distanza di tre settimane l\u2019una dall\u2019altra.<br \/>\nI dati disponibili, rileva la CTS, sul vaccino Nuvaxovid hanno mostrato una efficacia di circa il 90% nel prevenire la malattia COVID-19 sintomatica anche nella popolazione di et\u00e0 superiore ai 64 anni. Il profilo di sicurezza si \u00e8 dimostrato positivo, con reazioni avverse prevalentemente di tipo locale.<\/p>\n<p>fonte: <a href=\"https:\/\/www.aifa.gov.it\/-\/aifa-approva-vaccino-nuvaxovid\">Aifa<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>photo by Natalyia Vaitkevic &nbsp; La Commissione Tecnico Scientifica (CTS) di AIFA, nella riunione del 22 dicembre 2021, ha approvato l\u2019utilizzo del vaccino Nuvaxovid (Novavax), rendendolo disponibile nell\u2019intera indicazione autorizzata da EMA per i soggetti di et\u00e0 uguale o superiore ai 18 anni. La vaccinazione prevede un ciclo vaccinale primario di due dosi a distanza di tre settimane l\u2019una dall\u2019altra. I dati disponibili, rileva la CTS, sul vaccino Nuvaxovid hanno mostrato una efficacia di circa il 90% nel prevenire la&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1175984,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[3376,3377,2628],"class_list":["post-1175983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-novavavax","tag-nuovo","tag-vaccino"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by Natalyia Vaitkevic &nbsp; La Commissione Tecnico Scientifica (CTS) di AIFA, nella riunione del 22 dicembre 2021, ha approvato l\u2019utilizzo del vaccino Nuvaxovid (Novavax), rendendolo disponibile nell\u2019intera indicazione autorizzata da EMA per i soggetti di et\u00e0 uguale o superiore ai 18 anni. La vaccinazione prevede un ciclo vaccinale primario di due dosi a distanza di tre settimane l\u2019una dall\u2019altra. I dati disponibili, rileva la CTS, sul vaccino Nuvaxovid hanno mostrato una efficacia di circa il 90% nel prevenire la...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-23T07:28:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"AIFA approva il vaccino Nuvaxovid (Novavax)\",\"datePublished\":\"2021-12-23T07:28:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/\"},\"wordCount\":113,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pexels-nataliya-vaitkevich-5863316-scaled.jpg\",\"keywords\":[\"novavavax\",\"nuovo\",\"vaccino\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/\",\"name\":\"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pexels-nataliya-vaitkevich-5863316-scaled.jpg\",\"datePublished\":\"2021-12-23T07:28:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pexels-nataliya-vaitkevich-5863316-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pexels-nataliya-vaitkevich-5863316-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/aifa-approva-il-vaccino-nuvaxovid-novavax\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIFA approva il vaccino Nuvaxovid (Novavax)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/","og_locale":"en_US","og_type":"article","og_title":"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners","og_description":"photo by Natalyia Vaitkevic &nbsp; La Commissione Tecnico Scientifica (CTS) di AIFA, nella riunione del 22 dicembre 2021, ha approvato l\u2019utilizzo del vaccino Nuvaxovid (Novavax), rendendolo disponibile nell\u2019intera indicazione autorizzata da EMA per i soggetti di et\u00e0 uguale o superiore ai 18 anni. La vaccinazione prevede un ciclo vaccinale primario di due dosi a distanza di tre settimane l\u2019una dall\u2019altra. I dati disponibili, rileva la CTS, sul vaccino Nuvaxovid hanno mostrato una efficacia di circa il 90% nel prevenire la...","og_url":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/","og_site_name":"Frezza Partners","article_published_time":"2021-12-23T07:28:51+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"AIFA approva il vaccino Nuvaxovid (Novavax)","datePublished":"2021-12-23T07:28:51+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/"},"wordCount":113,"image":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","keywords":["novavavax","nuovo","vaccino"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/","url":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/","name":"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","datePublished":"2021-12-23T07:28:51+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/aifa-approva-il-vaccino-nuvaxovid-novavax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"AIFA approva il vaccino Nuvaxovid (Novavax)"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1175983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1175983"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1175983\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1175984"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1175983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1175983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1175983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}